Biological therapies directed against cells in autoimmune disease (Q36494222)

14 August 2017

1 reference

title

Biological therapies directed against cells in autoimmune disease (English)

1 reference

14 August 2017

1 reference

Paul Hasler

1

1 reference

14 August 2017

28 April 2006

1 reference

Seminars in Immunopathology

14 August 2017

1 reference

14 August 2017

27

1 reference

14 August 2017

4

1 reference

14 August 2017

443-456

1 reference

https://scigraph.springernature.com/pub.10.1007/s00281-006-0013-8

14 August 2017

0 references

cites work

Regulatory CD8+ T cells control neonatal tolerance to a Th2-mediated autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS00281-006-0013-8

Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-006-0013-8

Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-006-0013-8

Induction of Immunological Tolerance/Hyporesponsiveness in Baboons with a Nondepleting CD4 Antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-006-0013-8

Lymphoid neogenesis in rheumatoid synovitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-006-0013-8

T cell activation in rheumatoid synovium is B cell dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-006-0013-8

Immune complexes present in the sera of autoimmune mice activate rheumatoid factor B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00281-006-0013-8

21 January 2018

1 reference

12 December 2020

Citrullination of synovial proteins in murine models of rheumatoid arthritis

1 reference

12 December 2020

Efficacy and safety of rituximab in type II mixed cryoglobulinemia

1 reference

12 December 2020

Temporary, but essential requirement of CD8+ T cells early in the pathogenesis of diabetes in BB rats as revealed by thymectomy and CD8 depletion

1 reference

12 December 2020

The role of cytokines and their inhibitors in arthritis

1 reference

12 December 2020

Adhesion molecules in autoimmune disease

1 reference

12 December 2020

Synovial tissue response to treatment with Campath-1H

1 reference

12 December 2020

Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice

1 reference

12 December 2020

Sustained improvement in rheumatoid arthritis following a protocol designed to deplete B lymphocytes

1 reference

12 December 2020

Citrullinated proteins: sparks that may ignite the fire in rheumatoid arthritis

1 reference

12 December 2020

Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis

1 reference

12 December 2020

Efficacy of selective B cell blockade in the treatment of rheumatoid arthritis: evidence for a pathogenetic role of B cells

1 reference

12 December 2020

Mast cells: a cellular link between autoantibodies and inflammatory arthritis

1 reference

12 December 2020

A novel targeted T-cell modulator, efalizumab, for plaque psoriasis

1 reference

12 December 2020

Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion

1 reference

12 December 2020

Differential clinical efficacy of anti-CD4 monoclonal antibodies in rat adjuvant arthritis is paralleled by differential influence on NF-kappaB binding activity and TNF-alpha secretion of T cells

1 reference

12 December 2020

Safety of rituximab in the treatment of B cell malignancies: implications for rheumatoid arthritis

1 reference

12 December 2020

The role of B cells in the pathogenesis of rheumatoid arthritis.

1 reference

12 December 2020

Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse

1 reference

12 December 2020

The pharmacokinetics and human anti-mouse antibody response in rheumatoid arthritis patients treated with a chimeric anti-CD4 monoclonal antibody

1 reference

12 December 2020

Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens

1 reference

12 December 2020

Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

1 reference

12 December 2020

Anti-CD20 monoclonal antibody (rituximab) as an adjunct in the treatment of giant cell arteritis

1 reference

12 December 2020

Complement. First of two parts

1 reference

12 December 2020

High efficacy of Rituximab in indolent HCV-related lymphoproliferative disorders associated with systemic autoimmune diseases

1 reference

12 December 2020

Treatment of inflammatory and paraproteinemic neuropathies

1 reference

12 December 2020

B cell targeted therapies

1 reference

12 December 2020

CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritis.

1 reference

12 December 2020

Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs

1 reference

12 December 2020

A randomized, double blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis

1 reference

12 December 2020

Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis

1 reference

12 December 2020

Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases

1 reference

12 December 2020

Regulatory CD8+ T cells fine-tune the myelin basic protein-reactive T cell receptor V beta repertoire during experimental autoimmune encephalomyelitis

1 reference

12 December 2020

Autoimmunity in thrombotic thrombocytopenic purpura

1 reference

12 December 2020

Clinical outcome in 22 patients with rheumatoid arthritis treated with B lymphocyte depletion

1 reference

12 December 2020

Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells

1 reference

12 December 2020

Apoptotic effect of rituximab on peripheral blood B cells in rheumatoid arthritis

1 reference

12 December 2020

CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis

1 reference

12 December 2020

Regulatory T cells in rheumatoid arthritis

1 reference

12 December 2020

Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

1 reference

12 December 2020

Elevated levels of circulating tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 in systemic reactions induced by anti-CD4 therapy in patients with rheumatoid arthritis

1 reference

12 December 2020

Effective treatment of a mouse model of Sjögren's syndrome with eyedrop administration of anti-CD4 monoclonal antibody

1 reference

12 December 2020

Nondepleting humanized anti-CD4 monoclonal antibody in patients with refractory rheumatoid arthritis

1 reference

12 December 2020

Antigen-specific T cells in rheumatoid arthritis

1 reference

12 December 2020

Recent advances in the management of ocular complications of Sjögren's syndrome

1 reference

12 December 2020

Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy

1 reference

12 December 2020

HuMax-CD4: a fully human monoclonal anti-CD4 antibody for the treatment of psoriasis vulgaris.

1 reference

12 December 2020

CD3-specific antibody-induced active tolerance: from bench to bedside

1 reference

12 December 2020

Complement. Second of two parts

1 reference

12 December 2020

Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation

1 reference

12 December 2020

A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantation

1 reference

12 December 2020

Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

1 reference

12 December 2020

Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis

1 reference

12 December 2020

Ectopic Germinal Center Formation in Rheumatoid Synovitis

1 reference

12 December 2020

Repeat-cycle study of high-dose intravenous 4162W94 anti-CD4 humanized monoclonal antibody in rheumatoid arthritis. A randomized placebo-controlled trial

1 reference

12 December 2020

Intra-articular primatised anti-CD4: efficacy in resistant rheumatoid knees. A study of combined arthroscopy, magnetic resonance imaging, and histology

1 reference

12 December 2020

A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis

1 reference

12 December 2020

Prevention of adjuvant arthritis by the W3/25 anti-CD4 monoclonal antibody is associated with a decrease of blood CD4(+)CD45RC(high) T cells

1 reference

12 December 2020

Generation and characterization of LymphoStat‐B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator

1 reference

12 December 2020

Therapeutic use of monoclonal anti-CD4 antibody in rheumatoid arthritis

1 reference

12 December 2020

CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose

1 reference

12 December 2020

A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator Group

1 reference

12 December 2020

Immunologic assessment during treatment of rheumatoid arthritis with anti-CD5 immunoconjugate

1 reference

12 December 2020

10.1007/S00281-006-0013-8

Identifiers

DOI

1 reference

14 August 2017

1 reference

PubMed ID

16738955